News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Crucell N.V. Announces 2005 Annual Results
January 24, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL) today announced its financial results for the fourth quarter and full year 2005.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
·
6 min read
·
Angela Gabriel
Opinion
Trump Must Make Biotech Innovation a National Priority
January 14, 2026
·
7 min read
·
Cyriac Roeding
Business
JPM26: Novo Refocuses on Diabetes and Obesity Amid Push To Expand GLP-1 Market
January 14, 2026
·
3 min read
·
Nick Paul Taylor
